Credit Suisse’s Viemed Healthcare VMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-19
Closed 4318
2022
Q2
$0 Buy
+19
New +$102 ﹤0.01% 4351
2021
Q2
Sell
-49,783
Closed -$504K 4627
2021
Q1
$504K Buy
49,783
+859
+2% +$8.09K ﹤0.01% 3761
2020
Q4
$379K Buy
48,924
+28,691
+142% +$252K ﹤0.01% 3902
2020
Q3
$175K Sell
20,233
-2,751
-12% -$27.8K ﹤0.01% 3862
2020
Q2
$221K Buy
+22,984
New +$179K ﹤0.01% 3698

Other funds holding VMD

Credit Suisse's VMD Position: Q3 2022 in Review

Credit Suisse sold out of Viemed Healthcare (VMD) in Q3 2022, closing a stake of 19 shares.

Credit Suisse first reported a position in VMD in Q2 2020 and held it in 5 quarters. The position peaked at $504K in Q1 2021. 65 funds tracked by Wall St. Rank hold VMD as of Q3 2022.

  • Credit Suisse reported no remaining Viemed Healthcare position as of Q3 2022 after selling out during the quarter.
  • Credit Suisse sold 19 Viemed Healthcare shares in Q3 2022.
  • Credit Suisse first reported a position in Viemed Healthcare in Q2 2020 and held it in 5 quarters.
  • Credit Suisse's Viemed Healthcare position peaked at $504K in Q1 2021.
  • 65 funds tracked by Wall St. Rank held Viemed Healthcare as of Q3 2022.

Based on Credit Suisse's 13F filing for Q3 2022, filed 10 Nov 2022.